Tesamorelin – 10 mg

Advanced Growth Hormone-Releasing Factor Analogue | Metabolic & Endocrine Research

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), a naturally occurring hormone responsible for stimulating growth hormone production within the body.

Comprising a modified 44-amino-acid sequence, Tesamorelin has attracted significant scientific interest for its effects on growth hormone signalling, lipid metabolism and visceral adipose tissue regulation.

Unlike compounds that act directly as growth hormone, Tesamorelin stimulates the body's own growth hormone production through interactions with receptors in the anterior pituitary gland.

Its distinctive mechanism has made it an important subject of clinical research in endocrinology, metabolic health and body-fat distribution.

How Does Tesamorelin Work?

Tesamorelin activates growth hormone-releasing hormone receptors, influencing several biological pathways:

• Growth Hormone Stimulation: Promotes the release of endogenous growth hormone (GH) from the anterior pituitary gland.

• Visceral Fat Regulation: Clinically investigated for its ability to reduce excess visceral adipose tissue, particularly in adults with HIV-associated lipodystrophy.

• IGF-1 Signalling: Stimulates pathways associated with insulin-like growth factor 1 (IGF-1), an important mediator of growth hormone activity.

• Lipid Metabolism: Investigated for its influence on fat mobilisation, lipolysis and metabolic regulation.

• Body Composition Research: Studied for changes in abdominal fat distribution and associated metabolic markers.

• Endocrine Function: Provides researchers with opportunities to investigate the relationship between hypothalamic signalling, pituitary function and growth hormone secretion.

Key Research Areas

• Growth hormone and IGF-1 regulation

• Visceral adipose tissue reduction

• Lipolysis and lipid metabolism

• Body composition and fat distribution

• Endocrine and pituitary signalling

• Metabolic health and glucose regulation

• Growth hormone-releasing hormone receptor activity

Product Information

Product: Tesamorelin
Strength: 10 mg
Classification: Synthetic Growth Hormone-Releasing Factor Analogue
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S (free peptide)
Molecular Weight: Approximately 5135.9 Da
Brand: Helix Bio-Science

Important Research Disclaimer

Tesamorelin is a prescription medicine approved in the United States for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight-loss management or bodybuilding purposes.

Research-grade Tesamorelin products should not be considered equivalent to approved pharmaceutical formulations.

Potential risks associated with Tesamorelin include elevated IGF-1 levels, fluid retention, joint discomfort and impaired glucose regulation.

For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.